Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Dimensions has found 56 publications that cite this research output.

Article in American Journal of Clinical Dermatology (December 2022)

Article in Virology (November 2022)

Article in Cancers (October 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.